Genetic and molecular advancements in combined hepatocellular-cholangiocarcinoma: Addressing a persistent clinical conundrum
Owing to the heterogeneous histomorphology and variable proportion presentation of cholangiocarcinoma (CCa) and hepatocellular carcinoma (HCC), accurate diagnosis and treatment of combined or mixed hepatocellular cholangiocarcinoma (CHC) remains a critical conundrum (Chu et al., 2024). The rare hepatic neoplasm account...